placeholder image

Mark P. Legolvan Assistant Professor of Pathology and Laboratory Medicine (Clinical)

Expertise/Certifications: Anatomic Pathology, Hematopathology, Hematology, Gastrointestinal (GI) Pathology, Clinical Pathology
Office number: 444-5169
(Lab Customer Service: 401-793-4242)

Dr. LeGolvan is on the faculty of Pathology and Laboratory Medicine at the Warren Alpert School of Medicine at Brown University, and a Staff Pathologist and Hematopathologist for Lifespan Academic Medical Center.  Dr. LeGolvan obtained his BA from College of Holy Cross in Worcester, MA, his Masters Coursework in Biology at Harvard University Extension School, and his Doctor of Osteopathic Medicine from the University of New England College of Osteopathic Medicine, Biddeford, ME.  He completed his pathology residency training (AP/CP) at Brown University, his GI/Hepatic Fellowship at Brown University, and his Hematopathology Fellowship at University of Massachusetts.  He is board-certified in Anatomic Pathology, Clinical Pathology, and Hematopathology, with special interests in using the most advanced molecular diagnostic techniques for personalized approach to management of cancer.

Prior academic appointments:
Fellow, University of Massachusetts

Brown Affiliations

scholarly work

Andrianov, A, Svirkin Y, and LeGolvan M, Synthesis and Biologically Relevant Properties of Polyphosphazene Polyacids. Biomacromolecules 2004; 5(5): 1999-2006.

Andrianov A, Chen J, and LeGolvan M.  Poly(dichlorophosphazene) As a Precursor for Biologically Active Polyphosphazenes: Synthesis, Characterization, and Stabilization. Macromolecules 2004; 37(2): 414-420.

Glasser L, LeGolvan M, and Horwitz H, Florid Histiocytic Hemophagocytosis Following Therapy with Long Acting G-CSF. American Journal of Hematology, 2007 Aug;82(8):753-7.

LeGolvan MP, Resnick M. Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. Journal of Surgical Oncology. 2010; Dec; 102(8):898-908.

Alverson B, Alexander N, LeGolvan MP, Dunlap W, Levy. A human immunodeficiency virus-positive infant with probable congenital histoplasmosis in a nonendemic area. Pediatric Infectious Disease Journal. 2010 Nov:29 (11): 1055-7.

Dobrilovic N, Singh AK, LeGolvan M, Sellke FW. Massive cardiac fibroma. J Card Surg. 2011 Mar;26(2):159-61.

McNeal SI, LeGolvan MP, Chung CS, Ayala A. The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis. Shock. 2011 May;35(5):499-505.

LeGolvan MP, Taliano RJ, Resnick MB. Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach. Hum Pathol. 2012 Aug;43(8):1157-68.

Wanebo HJ, LeGolvan M, Paty PB, Saha S, Zuber M, D'Angelica MI, Kemeny NE. Meeting the biologic challenge of colorectal metastases. Clin Exp Metastasis. 2012 Oct;29(7):821-39.

Taliano RJ, LeGolvan M, Resnick MB. Immunohistochemistry of colorectal carcinoma: current practice and evolving applications. Hum Pathol. 2013 Feb;44(2):151-63.

research overview

Dr. LeGolvan is interested in using the most advanced molecular diagnostic techniques to develop personalized approaches in the management of cancer.